Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile.

Overview of attention for article published in New England Journal of Medicine, January 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#21 of 18,884)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Readers on

mendeley
1316 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile.
Published in
New England Journal of Medicine, January 2013
DOI 10.1056/nejmoa1205037
Pubmed ID
Authors

Els van Nood, Anne Vrieze, Max Nieuwdorp, Susana Fuentes, Erwin G. Zoetendal, Willem M. de Vos, Caroline E. Visser, Ed J. Kuijper, Joep F.W.M. Bartelsman, Jan G.P. Tijssen, Peter Speelman, Marcel G.W. Dijkgraaf, Josbert J. Keller, van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ, van Nood, Els

Abstract

Recurrent Clostridium difficile infection is difficult to treat, and failure rates for antibiotic therapy are high. We studied the effect of duodenal infusion of donor feces in patients with recurrent C. difficile infection.

Twitter Demographics

The data shown below were collected from the profiles of 1,043 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 1,316 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 38 3%
United Kingdom 18 1%
Canada 11 <1%
Japan 11 <1%
Brazil 9 <1%
Spain 8 <1%
Denmark 7 <1%
France 7 <1%
Germany 5 <1%
Other 34 3%
Unknown 1168 89%

Demographic breakdown

Readers by professional status Count As %
Researcher 277 21%
Student > Ph. D. Student 216 16%
Student > Bachelor 159 12%
Other 149 11%
Student > Master 148 11%
Other 367 28%
Readers by discipline Count As %
Medicine and Dentistry 713 54%
Agricultural and Biological Sciences 382 29%
Biochemistry, Genetics and Molecular Biology 62 5%
Immunology and Microbiology 27 2%
Chemistry 23 2%
Other 109 8%

Attention Score in Context

This research output has an Altmetric Attention Score of 1612. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2017.
All research outputs
#413
of 7,436,043 outputs
Outputs from New England Journal of Medicine
#21
of 18,884 outputs
Outputs of similar age
#7
of 295,285 outputs
Outputs of similar age from New England Journal of Medicine
#3
of 318 outputs
Altmetric has tracked 7,436,043 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 18,884 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 43.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 295,285 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 318 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.